Skip to main content
. 2014 Mar 26;8(5):956–967. doi: 10.1016/j.molonc.2014.03.005

Figure 1.

Figure 1

Compound structures and cell killing characteristics of SW IV‐134. (A) Chemical structures of the drugs used in the current study. IC50 of (B) KCM and (C) AsPC‐1. Cells were treated with different concentrations of SW IV‐134, SW43, SW IV‐52, and a combination of SW IV‐52 with SW43. Titer‐Glo viability assay was performed 24 h later. IC50 was expressed as mean ± SEM, n ≥ 3.